Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Projected Burden of Melanoma Clinical Surveillance
Description
Charles Ellis from the University of Michigan and the VA hospital presented an analysis on the projected burden of melanoma clinical surveillance. He highlighted the growing prevalence of melanoma, noting it is the fifth most diagnosed cancer in the U.S., particularly affecting individuals under 65, and leading to an increased demand for full-body skin exams. The team utilized U.S. guidelines from AAD and NCCN, combining census data and melanoma prevalence statistics to project the number of recommended exams. Their findings suggest a significant rise in required full body skin exams, with demands depending on patient attrition rates. The conservative and aggressive surveillance models indicate that a projected need for 1,000 to 2,000 more dermatologists in the coming years will be necessary to meet this demand. The results emphasize the necessity for adaptable dermatological practices, potentially including teledermatology. Ellis encouraged participants to consider how these projections could impact their practices, providing tools for individual estimation of future patient exam loads based on different attrition rates. In conclusion, he cautioned that dermatologists should prepare for increased demand on their clinical time as melanoma surveillance needs continue to grow.
View moreConclusions
- The projected need for melanoma surveillance will significantly increase over the coming years.
- Aggressive surveillance requires more frequent full body skin exams compared to conservative approaches.
- An estimated additional 1,000 to 2,000 dermatologists will be needed to meet the rising demand for melanoma examinations.
- Patient attrition rates will impact the efficacy of surveillance recommendations.
- Projected numbers may underestimate surveillance needs due to the lack of melanoma stage data.
- Practices will face increasing demand that could strain clinical resources in the future.
- Guidelines from AAD and NCCN will play a key role in shaping melanoma surveillance practices.
- An increase in melanoma prevalence is expected as survival rates improve.
- Mariotto A.B., et al. 2020. "Cancer Epidemiology, Biomarkers & Prevention."
- Glazer A.M. 2017. "JAMA Dermatology."